523 related articles for article (PubMed ID: 31462078)
21. Review on Bile Acids: Effects of the Gut Microbiome, Interactions with Dietary Fiber, and Alterations in the Bioaccessibility of Bioactive Compounds.
Singh J; Metrani R; Shivanagoudra SR; Jayaprakasha GK; Patil BS
J Agric Food Chem; 2019 Aug; 67(33):9124-9138. PubMed ID: 30969768
[TBL] [Abstract][Full Text] [Related]
22. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
Swanson HI
Drug Metab Dispos; 2015 Oct; 43(10):1499-504. PubMed ID: 26261284
[TBL] [Abstract][Full Text] [Related]
23. Gut metabolome meets microbiome: A methodological perspective to understand the relationship between host and microbe.
Lamichhane S; Sen P; Dickens AM; Orešič M; Bertram HC
Methods; 2018 Oct; 149():3-12. PubMed ID: 29715508
[TBL] [Abstract][Full Text] [Related]
24. Microbiota and HDL metabolism.
Nakaya K; Ikewaki K
Curr Opin Lipidol; 2018 Feb; 29(1):18-23. PubMed ID: 29135690
[TBL] [Abstract][Full Text] [Related]
25. Multi-Omics Reveals that Lead Exposure Disturbs Gut Microbiome Development, Key Metabolites, and Metabolic Pathways.
Gao B; Chi L; Mahbub R; Bian X; Tu P; Ru H; Lu K
Chem Res Toxicol; 2017 Apr; 30(4):996-1005. PubMed ID: 28234468
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiome and its role in cardiovascular diseases.
Ahmadmehrabi S; Tang WHW
Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
[TBL] [Abstract][Full Text] [Related]
27. Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability.
Tsunoda SM; Gonzales C; Jarmusch AK; Momper JD; Ma JD
Clin Pharmacokinet; 2021 Aug; 60(8):971-984. PubMed ID: 33959897
[TBL] [Abstract][Full Text] [Related]
28. The Role of Gut Microbiota in Hypertension Pathogenesis and the Efficacy of Antihypertensive Drugs.
Xiong Y; Xiong Y; Zhu P; Wang Y; Yang H; Zhou R; Shu Y; Zhou H; Li Q
Curr Hypertens Rep; 2021 Sep; 23(8):40. PubMed ID: 34487269
[TBL] [Abstract][Full Text] [Related]
29. The role of gut microbiota in fetal methylmercury exposure: Insights from a pilot study.
Rothenberg SE; Keiser S; Ajami NJ; Wong MC; Gesell J; Petrosino JF; Johs A
Toxicol Lett; 2016 Feb; 242():60-67. PubMed ID: 26626101
[TBL] [Abstract][Full Text] [Related]
30. The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.
Enright EF; Gahan CG; Joyce SA; Griffin BT
Yale J Biol Med; 2016 Sep; 89(3):375-382. PubMed ID: 27698621
[TBL] [Abstract][Full Text] [Related]
31. Differential Profiles of Gut Microbiota and Metabolites Associated with Host Shift of
Yang FY; Saqib HSA; Chen JH; Ruan QQ; Vasseur L; He WY; You MS
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872681
[TBL] [Abstract][Full Text] [Related]
32. The emerging role of gut microbial metabolism on cardiovascular disease.
Kasahara K; Rey FE
Curr Opin Microbiol; 2019 Aug; 50():64-70. PubMed ID: 31693963
[TBL] [Abstract][Full Text] [Related]
33. Manipulation and assessment of gut microbiome for metabolic studies.
Satoor SN; Patil DP; Kristensen HD; Joglekar MV; Shouche Y; Hardikar AA
Methods Mol Biol; 2014; 1194():449-69. PubMed ID: 25064120
[TBL] [Abstract][Full Text] [Related]
34. Insights from pharmacokinetic models of host-microbiome drug metabolism.
Zimmermann-Kogadeeva M; Zimmermann M; Goodman AL
Gut Microbes; 2020 May; 11(3):587-596. PubMed ID: 31564204
[TBL] [Abstract][Full Text] [Related]
35. High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice.
Marques FZ; Nelson E; Chu PY; Horlock D; Fiedler A; Ziemann M; Tan JK; Kuruppu S; Rajapakse NW; El-Osta A; Mackay CR; Kaye DM
Circulation; 2017 Mar; 135(10):964-977. PubMed ID: 27927713
[TBL] [Abstract][Full Text] [Related]
36. Microbial endocrinology: host-bacteria communication within the gut microbiome.
Sandrini S; Aldriwesh M; Alruways M; Freestone P
J Endocrinol; 2015 May; 225(2):R21-34. PubMed ID: 25792117
[TBL] [Abstract][Full Text] [Related]
37. Ginsenosides, catechins, quercetin and gut microbiota: Current evidence of challenging interactions.
Santangelo R; Silvestrini A; Mancuso C
Food Chem Toxicol; 2019 Jan; 123():42-49. PubMed ID: 30336256
[TBL] [Abstract][Full Text] [Related]
38. Role of the gut microbiome in cardiovascular drug response: The potential for clinical application.
Steiner HE; Gee K; Giles J; Knight H; Hurwitz BL; Karnes JH
Pharmacotherapy; 2022 Feb; 42(2):165-176. PubMed ID: 34820870
[TBL] [Abstract][Full Text] [Related]
39. Interaction between gut microbiome and cardiovascular disease.
Peng J; Xiao X; Hu M; Zhang X
Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
[TBL] [Abstract][Full Text] [Related]
40. Unraveling the drivers and consequences of gut microbiota disruption in Fabry disease: the lyso-Gb3 link.
Sanchez-Niño MD; Aguilera-Correa JJ; Politei J; Esteban J; Requena T; Ortiz A
Future Microbiol; 2020 Mar; 15():227-231. PubMed ID: 32271110
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
